FDA Adverse Event Injury Summary report: N

ZIMMER TRABECULAR METAL TOTAL ANKLE

MDR report key: 22142558 · Received June 4, 2025

Report

Report Number
0001822565-2025-01664
Event Type
Injury
Date Received
June 4, 2025
Report Date
June 4, 2025
Manufacturer
ZIMMER BIOMET, INC.
Product Code
HSN
PMA / PMN Number
NI
Removal / Correction Number
NI
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

(B)(4). D10: . E1: FULL ESTABLISHMENT NAME - (B)(6) HOSPITAL. G2: FOREIGN - EVENT OCCURRED IN SPAIN. G2: LITERATURE - HERNÁNDEZ-JIMÉNEZ, P., MANCHEÑO-LOSA, M., MELÉNDEZ-CARMONA, M. Á., MELLADO-ROMERO, M. Á., BRAÑAS, P., LUMBRERAS-BERMEJO, C., VILÁ Y RICO, J. E., & LORA-TAMAYO, J. (2025). PERIPROSTHETIC INFECTION OF TRANSFIBULAR ANKLE ARTHROPLASTIES MANAGED WITH IMPLANT RETENTION: ANATOMICAL LIMITATIONS OF SURGICAL DEBRIDEMENT. ANTIBIOTICS, 14(3), 215. HTTPS://DOI.ORG/10.3390/ANTIBIOTICS14030215. ATTEMPTS HAVE BEEN MADE TO GATHER PRODUCT ID INFORMATION AND NO FURTHER INFO IS AVAILABLE. NO PRODUCT WAS RETURNED OR PICTURES PROVIDED; VISUAL AND DIMENSIONAL EVALUATIONS COULD NOT BE PERFORMED. MEDICAL RECORDS WERE NOT PROVIDED. PART AND LOT IDENTIFICATION ARE NECESSARY FOR REVIEW OF DEVICE HISTORY RECORDS, NEITHER WERE PROVIDED. A DEFINITIVE ROOT CAUSE CANNOT BE DETERMINED. SINGLE-USE, STERILIZED DEVICES MANUFACTURED OR DISTRIBUTED BY ZIMMER BIOMET ARE STERILIZED IN ACCORDANCE WITH FDA REGULATIONS AND ISO STANDARDS TO A STERILITY ASSURANCE LEVEL OF 1.0 X 10-6 OR BETTER. THEREFORE, IT IS UNLIKELY THAT THE SPECIFIED DEVICE CAUSED ANY PATIENT INFECTION. THE REPORTED EVENT IS UNCONFIRMED. IF ANY FURTHER INFORMATION WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 0

IT WAS REPORTED THAT APPROXIMATELY FOUR (4) WEEKS AGO, A JOURNAL ARTICLE WAS RETRIEVED FROM ANTIBIOTICS THAT REPORTED A STUDY FROM SPAIN. THE PURPOSE OF THE STUDY WAS TO ANALYZE OUR EXPERIENCE IN THE MANAGEMENT OF PROSTHETIC ANKLE INFECTIONS (PAI) BY FOCUSING ON THE PECULIARITIES OF TRANSFIBULAR APPROACH WITH SPECIAL ATTENTION TO CASES MANAGED WITH IRRIGATION AND DEBRIDEMENT LIMITED TO THE FIBULAR PLATE. THE STUDY REVIEWED A TOTAL OF 291 EPISODES OF PROSTHETIC JOINT INFECTION (PJI) AT THEIR CENTER, 10 WITH ANKLE ARTHROPLASTIES AND OF THESE 10, 7 WERE THE TRANSFIBULAR APPROACH. PROTHESES IMPLANTED VIA TRANSFIBULAR WERE TM ANKLER (ZIMMER BIOMET, WARSAW, IN). THE INDICATION FOR SURGERY WAS FOUR PATIENTS WITH POST-TRAUMATIC INJURY, TWO WITH ARTHROSIS, AND ONE WITH A CHRONIC INFLAMMATORY DISEASE. THE STUDY REPORTED ONE PATIENT HAD AN INITIAL ANKLE ARTHROPLASTY DUE TO POST-TRAUMATIC INJURY AND SUBSEQUENTLY DEVELOPED AN E. CLOACAE INFECTION APPROXIMATELY 11 DAYS POST TOTAL ANKLE ARTHROPLASTY. AN INCISION AND DRAINAGE WAS PERFORMED WITH OSTEOSYNTHESIS MATERIAL REMOVAL AND FLAP COVERAGE. NO ANKLE COMPONENTS WERE REVISED. ANTIBIOTIC TREATMENT PROVIDED, NO FURTHER COMPLICATIONS REPORTED. RADIOGRAPHS AT LAST FOLLOW UP SHOWED CONSOLIDATION AND PATIENT AMBULATING WITHOUT ASSISTANCE. ATTEMPTS HAVE BEEN MADE AND NO FURTHER INFORMATION HAS BEEN PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
829707 ZIMMER TRABECULAR METAL TOTAL ANKLE PROSTHESIS, ANKLE, SEMI-CONSTRAINED HSN ZIMMER BIOMET, INC. NI UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 54 YR Unknown Hospitalization| R SEE NARRATIVE IN H11